DISCOUNT ZERTIFIKAT - BIOGEN IDEC | Market Closed - Boerse Frankfurt Warrants 11:33:18 31/05/2024 pm IST | ||
| 198 EUR | +1.99% |
|
| 1 month | +1.25% | ||
| 3 months | +1.98% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 31/24/31 | 198 | +1.99% |
| 30/24/30 | 194.2 | +0.97% |
| 29/24/29 | 192.3 | -0.14% |
| 28/24/28 | 192.6 | -0.29% |
| 27/24/27 | 193.2 | -0.18% |
Real-time Boerse Frankfurt Warrants
Last update May 31, 2024 at 11:33 pm IST
More quotesStatic data
| Product type | Discount Certificates |
|---|---|
| Buy / Sell | CALL |
| Underlying | BIOGEN INC. |
| Issuer | 
Vontobel
|
| WKN | VM8BYN |
| ISIN | DE000VM8BYN2 |
| Date issued | 10/01/2024 |
| Maturity | 20/12/2024 (202 Days) |
| Parity | 1 : 1 |
| Emission price | 202 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 203.8 € |
|---|---|
| Lowest since issue | 175.9 € |
| Spread | 0.21 € |
| Spread % | 0.11% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
224.9
USD
Average target price
284.8
USD
Spread / Average Target
+26.60%
- Stock Market
- Certificates
- Certificat
